Search

everythinglearnresearchcommunity

for

Search:↓

TNF-α blockers and IL inhibitors improve symptoms in most patients with severe scalp condition, but more research is needed.

IL-17 inhibitors for psoriasis may cause unexpected hair loss.

IL-1β inhibits human hair follicle growth.

Testosterone increases cell growth and reduces IL-6 in gum cells.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

EGFRi/MEKi treatments cause hair follicles to lose some immune protection, leading to inflammation.

Blocking EGFR in skin cells doesn't majorly increase inflammation markers.

TNFα inhibitors are effective and well-tolerated for treating severe scalp cellulitis.

Melanogenesis inhibitors like kojic acid and niacinamide can reduce inflammation and pigment production in skin cells.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

Two patients with psoriasis grew extra hair after using certain psoriasis medications.

17β-estradiol can reduce inflammation in the skin.

The conclusion is that the IL-6/STAT3 activation affects p63 expression in healing wounds, which may help in hair follicle regeneration.

IL-1 alpha stops hair follicle growth and hair production.

A peptide known for reducing wrinkles also effectively inhibits an enzyme linked to skin inflammation and acne.

JAK inhibitors show promise for treating alopecia areata, but more research is needed.

New treatments like biologics and JAK inhibitors show promise for severe scalp inflammation when traditional methods fail.

There is no cure for alopecia areata, but treatments like JAK inhibitors show promise.

JAK inhibitors and platelet-rich plasma show promise for treating alopecia areata.

Blocking EGFR can cause skin inflammation by disrupting IL-1 signaling.

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.

Erlotinib causes skin inflammation through IL-1, which can be reduced by anakinra.

Hair regrows faster in alopecia areata than skin re-pigments in vitiligo due to differences in stem cells and treatment effects.

Alopecia areata is caused by immune system issues, and JAK inhibitors might help treat it.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

Childhood Alopecia Areata causes hair loss and requires varied treatments, with psychological support being crucial.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.

IL-15 helps maintain hair growth and protects the immune status of hair follicles.

In 2017, pediatric dermatology advanced with new treatments and insights into various skin conditions in children.